Illumina Stock Falls As Roche Says Buyout Talks Fail
Shares of genetics firm Illumina (ILMN) tumbled 9% in early trading Monday after Roche's (RHHBY) chairman said it was "off the table" as a buyout target. Meanwhile, Illumina made another buyout of its own. Over the weekend, Swiss newspaper SonntagsZeitung published an interview with Franz Humer in which the chairman said merger negotiations had broken down over price. Illumina turned down Roche's $6.8 billion bid in April, but last month its stock
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here